Sonoma Pharmaceuticals Ownership | Who Owns Sonoma Pharmaceuticals?


OverviewRevenueFinancialsChart

Sonoma Pharmaceuticals Ownership Summary


Sonoma Pharmaceuticals is owned by 5.17% institutional investors, 1.23% insiders, and 93.60% retail investors. Citadel advisors is the largest institutional shareholder, holding 1.25% of SNOA shares. Vanguard Institutional Extnd Mkt Idx Tr is the top mutual fund, with 1.14% of its assets in Sonoma Pharmaceuticals shares.

SNOA Ownership Benchmark


TypeName% Inst% Insiders% Retail
StockSonoma Pharmaceuticals5.17%1.23%93.60%
SectorHealthcare Stocks 488.17%11.08%-399.26%
IndustrySpecialty & Generic Drug Manufacturers Stocks43.51%11.55%44.95%

Institutional Shareholders


Top Institutional Shareholders by Total Shares

HolderShares% HoldingValue
Citadel advisors195.16K1.25%$41.41K
Geode capital management86.64K0.56%$18.39K
State street24.32K0.16%$5.16K
Ubs group11.92K0.08%$2.53K
Blackrock2.27K0.01%$481.00
Blackrock funding, inc. /de113.000.01%$321.00
Bank of america corp /de/172.000.00%$36.00
Morgan stanley86.000.00%$18.00
Allworth financial lp3.000.00%$9.00
Quaker wealth management3.000.00%$9.00

Top Institutional Shareholders by % of Total Assets

HolderShares% AssetsValue
Blackrock2.27K-$481.00
Tower research capital llc (trc)---
Two sigma securities---
Susquehanna group, llp---
Advisor group---
Bank of america corp /de/172.00-$36.00
Jane street group---
Millennium management---
Us bancorp \de\---
Geode capital management86.64K-$18.39K

Top Buyers

HolderShares% AssetsChange
Citadel advisors195.16K-195.16K
Geode capital management86.64K-50.86K
Ubs group11.92K-11.81K
Bank of america corp /de/172.00-128.00
Quaker wealth management3.00-3.00

Top Sellers

HolderShares% AssetsChange
Susquehanna group, llp---46.05K
Jane street group---45.30K
Xtx topco---19.83K
Two sigma securities---15.32K
Millennium management---13.02K

New Positions

HolderShares% AssetsChangeValue
Quaker wealth management3.00-3.00$9.00

Sold Out

HolderChange
Advisor group-200.00
Us bancorp \de\-500.00
Citigroup-811.00
Qube research-3.40K
Tower research capital llc (trc)-8.27K

Institutional Ownership Trends


DateHoldingsChange %SharesChange %OwnershipChange %Increased PositionChange %Decreased PositionChange %
Jun 30, 202512-84,901156.84%5101.48%5-2-
Mar 31, 20251233.33%33,05663.98%2119.08%5150.00%2100.00%
Dec 31, 20249-25.00%20,159-27.39%119.10%2-60.00%1-85.71%
Sep 30, 202412-29.41%27,765-93.62%241.15%5-50.00%7250.00%
Jun 30, 20241721.43%434,996164.81%2122.92%10100.00%2-

Top Mutual Funds Shareholders


HolderShares% HoldingChange
Vanguard Institutional Extnd Mkt Idx Tr18.79K1.14%12.12K
Fidelity Extended Market Index8.94K0.54%-
Spartan Extended Market Index Pool F3.02K0.18%-
Spartan Extended Market Index Pool E2.97K0.18%2.92K
Fidelity Total Market Index2.53K0.15%-
Fidelity Series Total Market Index2.31K0.14%-
Spartan Total Market Index Pool G812.000.05%-
Fidelity Nasdaq Composite Index248.000.02%-
Northern Trust Extended Eq Market Idx96.000.01%-
NT Ext Equity Mkt Idx Fd - L96.000.01%-

Recent Insider Transactions


DateNameRoleActivityValue
Mar 12, 2018Miller Robert E Chief Financial OfficerBuy$4.84K
Mar 13, 2018Miller Robert E Chief Financial OfficerBuy$4.92K
Mar 12, 2018Miller Robert E Chief Financial OfficerBuy$4.84K
Mar 09, 2018Miller Robert E Chief Financial OfficerBuy$4.68K
Mar 08, 2018Schutz James J Chief Executive OfficerBuy$9.87K

Insider Transactions Trends


DateBuySell
2025 Q2--
2025 Q1--
2024 Q2--
2023 Q4--
2023 Q3--

SNOA Ownership FAQ


Who Owns Sonoma Pharmaceuticals?

Sonoma Pharmaceuticals shareholders are primarily institutional investors at 5.17%, followed by 1.23% insiders and 93.60% retail investors. The average institutional ownership in Sonoma Pharmaceuticals's industry, Specialty & Generic Drug Manufacturers Stocks, is 43.51%, which Sonoma Pharmaceuticals falls below.

Who owns the most shares of Sonoma Pharmaceuticals?

Sonoma Pharmaceuticals’s largest shareholders are Citadel advisors (195.16K shares, 1.25%), Geode capital management (86.64K shares, 0.56%), and State street (24.32K shares, 0.16%). Together, they hold 1.96% of Sonoma Pharmaceuticals’s total shares outstanding.

Does Blackrock own Sonoma Pharmaceuticals?

Yes, BlackRock owns 0.01% of Sonoma Pharmaceuticals, totaling 2.27K shares as of Jun 2024. This represents 0% of BlackRock's total assets, with a market value of 481$. In the last quarter, BlackRock decreased its holdings by 0 shares, a 0% change.

Who is Sonoma Pharmaceuticals’s biggest shareholder by percentage of total assets invested?

Blackrock is Sonoma Pharmaceuticals’s biggest shareholder by percentage of total assets invested, with 0% of its assets in 2.27K Sonoma Pharmaceuticals shares, valued at 481$.

Who is the top mutual fund holder of Sonoma Pharmaceuticals shares?

Vanguard Institutional Extnd Mkt Idx Tr is the top mutual fund holder of Sonoma Pharmaceuticals shares, with 1.14% of its total shares outstanding invested in 18.79K Sonoma Pharmaceuticals shares.

Try Tickergate Pro Free

Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)

  • Customize your own personal stocks lists, views and charts

  • Choose from hundreds of fields, up to 15 years of history

  • Conduct deep comparison analysis

  • Discover trending investment themes

  • Find your next best investment

  • Research stocks using tools